Cargando…

Neoadjuvant PD-1 Blockade in Non-Small Cell Lung Cancer: Current perspectives and Moving Forward

Perioperative therapy for non-small cell lung cancer has been studied extensively in a bid to improve overall survival, as approximately half of the patients with surgically resectable tumors at the time of diagnosis relapse. In recent years, immune checkpoint inhibitor therapies, such as the anti-p...

Descripción completa

Detalles Bibliográficos
Autores principales: Shinada, Kanako, Murakami, Shuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939665/
https://www.ncbi.nlm.nih.gov/pubmed/36814961
http://dx.doi.org/10.2147/OTT.S399657

Ejemplares similares